Workflow
Rogaine
icon
Search documents
I-Mab morphs into ‘hub-and-spoke’ biotech; Astellas passes on Taysha gene therapy
Yahoo Finance· 2025-10-17 10:00
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Today, a brief rundown of news involving I-Mab Biopharma and Taysha Gene Therapies, as well as updates from Sanofi, Adcytherix and Boehringer Ingelheim that you may have missed. I-Mab Biopharma will change its name and pursue an initial public offering in Hong Kong as part of a transformation into a “hub-and-spoke” company with drugmaking subsidiaries. Following ...
X @mert | helius.dev
mert | helius.dev· 2025-07-17 19:48
some personal newsexcited to reveal that I'm starting the microstrategy for rogainewe will buy all the rogaine in the world, drive the prices up, and ensure mass adoption of baldnessmore to come! ...